🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study was to describe the time to tolerization ...
Status
Completed
Location
Center for Inherited Blood Disorders
Start Date
2017-12-08
Trial ID
NCT03093480
Treatments Being Tested
The primary purpose of this study is to describe the outcome of Immune Tole...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site
Start Date
2017-08-29
Trial ID
NCT03103542
Treatments Being Tested
The study is designed as a randomized, two-armed, double-blind, single-dose...
Status
Completed
Location
Seyed-Al-Shohada Hospital
Start Date
2023-07-22
Trial ID
NCT06137092
Treatments Being Tested
This is a 48-month observational, prospective, multicentre study. The overa...
Status
Active Not Recruiting
Location
University Hospital Brno
Start Date
2020-03-30
Trial ID
NCT04293523
Treatments Being Tested
The purpose of the study is to evaluate the effectiveness of Elocta compare...
Status
Completed
Location
Swedish Orphan Biovitrum Research site
Start Date
2016-12
Trial ID
NCT02976753
Treatments Being Tested
Haemophilia A and haemophilia B are inherited bleeding disorders resulting ...
Status
Unknown
Location
Centre de Référence en Hémophilie, hôpityal Louis Pradel, GHE- Hospices Civils de Lyon
Start Date
2022-06-01
Trial ID
NCT06158334
The primary objective of the study is to characterize the pharmacokinetics ...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02083965
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics of BAY94-9027 ...
Status
Completed
Location
SHATHD Spec. Hospi. for Active Treatm. of Haematol. Dis. EAD
Start Date
2017-11-30
Trial ID
NCT03364998
Treatments Being Tested
Elocta (rFVIIIFc) and Alprolix (rFIXFc) are recombinant extended half-life ...
Status
Completed
Location
Swedish Orphan Biovitrum Reserach site
Start Date
2017-05-09
Trial ID
NCT03055611
A chart review study of patients with haemophilia A with inhibitors treated...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site
Start Date
2018-11-07
Trial ID
NCT03951103
Treatments Being Tested